Podocytopathies

JB Kopp, HJ Anders, K Susztak, MA Podestà… - Nature Reviews …, 2020 - nature.com
Podocytopathies are kidney diseases in which direct or indirect podocyte injury drives
proteinuria or nephrotic syndrome. In children and young adults, genetic variants in> 50 …

Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation

LJH Rasmussen, JEV Petersen… - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …

The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease

T Yang, EM Richards, CJ Pepine… - Nature Reviews …, 2018 - nature.com
Crosstalk between the gut microbiota and the host has attracted considerable attention
owing to its involvement in diverse diseases. Chronic kidney disease (CKD) is commonly …

Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation

S Zewinger, J Reiser, V Jankowski, D Alansary… - Nature …, 2020 - nature.com
NLRP3-inflammasome-driven inflammation is involved in the pathogenesis of a variety of
diseases. Identification of endogenous inflammasome activators is essential for the …

Soluble urokinase receptor (SuPAR) in COVID-19–related AKI

TU Azam, HR Shadid, P Blakely… - Journal of the …, 2020 - journals.lww.com
Background AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its
pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the …

Soluble urokinase receptor and acute kidney injury

SS Hayek, DE Leaf, A Samman Tahhan… - … England Journal of …, 2020 - Mass Medical Soc
Background Acute kidney injury is common, with a major effect on morbidity and health care
utilization. Soluble urokinase plasminogen activator receptor (suPAR) is a signaling …

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

G Hindy, DJ Tyrrell, A Vasbinder, C Wei… - The Journal of …, 2022 - Am Soc Clin Investig
People with kidney disease are disproportionately affected by atherosclerosis for unclear
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …

Ion channels and channelopathies in glomeruli

A Staruschenko, R Ma, O Palygin… - Physiological …, 2023 - journals.physiology.org
An essential step in renal function entails the formation of an ultrafiltrate that is delivered to
the renal tubules for subsequent processing. This process, known as glomerular filtration, is …

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease

SS Hayek, KH Koh, ME Grams, C Wei, YA Ko, J Li… - Nature medicine, 2017 - nature.com
Soluble urokinase plasminogen activator receptor (suPAR) independently predicts chronic
kidney disease (CKD) incidence and progression. Apolipoprotein L1 (APOL1) gene variants …

[HTML][HTML] Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy against renal inflammation and …

TT Tang, LL Lv, B Wang, JY Cao, Y Feng, ZL Li… - Theranostics, 2019 - ncbi.nlm.nih.gov
Although glucocorticoids are the mainstays in the treatment of renal diseases for decades,
the dose dependent side effects have largely restricted their clinical use. Microvesicles …